The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(4-Amino-7-(3-morpholinopropyl)-7H-pyrrolo[2,3-d]-pyrimidin-5-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea ID: ALA4572804
PubChem CID: 155563426
Max Phase: Preclinical
Molecular Formula: C27H34N8O3
Molecular Weight: 518.62
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn(CCCN4CCOCC4)c4ncnc(N)c34)cc2)no1
Standard InChI: InChI=1S/C27H34N8O3/c1-27(2,3)21-15-22(33-38-21)32-26(36)31-19-7-5-18(6-8-19)20-16-35(25-23(20)24(28)29-17-30-25)10-4-9-34-11-13-37-14-12-34/h5-8,15-17H,4,9-14H2,1-3H3,(H2,28,29,30)(H2,31,32,33,36)
Standard InChI Key: DFFNBUFTNUREFC-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
19.5444 -12.4631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2501 -12.8752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2460 -13.6924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9598 -12.4702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9518 -13.2802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4092 -14.3999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4080 -15.2194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1161 -15.6284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1143 -13.9910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8229 -14.3963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8277 -15.2149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6077 -15.4633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0851 -14.7982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6000 -14.1388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1118 -13.1738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0205 -16.1685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8377 -16.1643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0132 -13.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8310 -13.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2449 -12.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8416 -12.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0201 -12.0267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6100 -12.7311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2545 -11.3251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0717 -11.3301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4847 -10.6250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4759 -12.0403 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2931 -12.0454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7657 -12.7108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5495 -11.6458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7739 -11.3886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2499 -16.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8450 -17.5797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0289 -17.5813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6240 -18.2871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0328 -18.9951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8510 -18.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2603 -18.2826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
2 5 1 0
6 7 2 0
7 8 1 0
8 11 2 0
10 9 2 0
9 6 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
9 15 1 0
12 16 1 0
16 17 1 0
14 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 1 0
25 26 2 0
25 27 1 0
27 28 1 0
28 29 1 0
29 1 2 0
1 30 1 0
30 31 1 0
31 28 2 0
17 32 1 0
32 33 1 0
33 34 1 0
33 38 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 518.62Molecular Weight (Monoisotopic): 518.2754AlogP: 4.33#Rotatable Bonds: 7Polar Surface Area: 136.36Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.27CX Basic pKa: 7.78CX LogP: 3.19CX LogD: 2.96Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -1.59
References 1. Yuan X, Chen Y, Zhang W, He J, Lei L, Tang M, Liu J, Li M, Dou C, Yang T, Yang L, Yang S, Wei Y, Peng A, Niu T, Xiang M, Ye H, Chen L.. (2019) Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia., 62 (8): [PMID:30939008 ] [10.1021/acs.jmedchem.9b00223 ]